Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for P32262

Entry ID Method Resolution Chain Position Source
AF-P32262-F1 Predicted AlphaFoldDB

No variants for P32262

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for P32262

No associated diseases with P32262

3 regional properties for P32262

Type Name Position InterPro Accession
conserved_site Serpin, conserved site 435 - 445 IPR023795
domain Serpin domain 87 - 462 IPR023796
domain Antithrombin-III, serpin domain 71 - 464 IPR033829

Functions

Description
EC Number
Subcellular Localization
  • Secreted, extracellular space
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
extracellular space That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.

4 GO annotations of molecular function

Name Definition
heparin binding Binding to heparin, a member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues.
identical protein binding Binding to an identical protein or proteins.
protease binding Binding to a protease or a peptidase.
serine-type endopeptidase inhibitor activity Binds to and stops, prevents or reduces the activity of serine-type endopeptidases, enzymes that catalyze the hydrolysis of nonterminal peptide bonds in a polypeptide chain; a serine residue (and a histidine residue) are at the active center of the enzyme.

2 GO annotations of biological process

Name Definition
blood coagulation The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.
regulation of blood coagulation, intrinsic pathway Any process that modulates the frequency, rate or extent of blood coagulation, intrinsic pathway.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MISNGIGTVT TGKRSMCLFP LLLIGLWGCV TCHRSPVEDI CTAKPRDIPV NPMCIYRSPE
70 80 90 100 110 120
KKATEGEGSE QKIPGATNRR VWELSKANSH FATAFYQHLA DSKNNNDNIF LSPLSISTAF
130 140 150 160 170 180
AMTKLGACNN TLKQLMEVFK FDTISEKTSD QIHFFFAKLN CRLYRKANKS SELVSANRLF
190 200 210 220 230 240
GDKSITFNET YQDISEVVYG AKLQPLDFKG NAEQSRLTIN QWISNKTEGR ITDVIPPQAI
250 260 270 280 290 300
DEFTVLVLVN TIYFKGLWKS KFSPENTKKE LFYKADGESC SVPMMYQEGK FRYRRVAEGT
310 320 330 340 350 360
QVLELPFKGD DITMVLILPK LEKPLAKVER ELTPDMLQEW LDELTETLLV VHMPHFRIED
370 380 390 400 410 420
SFSVKEQLQD MGLEDLFSPE KSRLPGIVAE GRNDLYVSDA FHKAFLEVNE EGSEAAASTV
430 440 450 460
ISIAGRSLNL NRVTFQANRP FLVLIREVAL NTIIFMGRVA NPCVN